FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a new keratin-binding effector molecule containing polypeptide sequences which have binding affinity with keratin, to preparation and use thereof. An available keratin-binding domain (domain B) is the polypeptide sequence SEQ ID NO:1 position 2193-2481, as well as its functional equivalents. A further keratin-binding domain (domain C) is the polypeptide sequence SEQ ID NO:1 position 2606-2871, as well as its functional equivalents, the domains are meant as human desmoplakin domains.
EFFECT: invention provides high-specific affinity with skin keratin of a subject.
17 cl, 41 ex, 8 dwg
Title | Year | Author | Number |
---|---|---|---|
USING HYDROPHOBIN POLYPEPTIDES AS PENETRATION INTENSIFIER | 2008 |
|
RU2491096C9 |
AGENT CONTAINING L-CARNITINE OR L-CARNITINE DERIVATIVES AND AT LEAST ONE OTHER CERTAIN SUBSTANCE | 2006 |
|
RU2407513C2 |
METHOD FOR TREATMENT AND/OR PREVENTION OF KERATIN DAMAGES | 2019 |
|
RU2793323C2 |
NOVEL COMPOSITIONS AND USE THEREOF | 2012 |
|
RU2604797C2 |
POLYURETHANES AS AGENTS MODIFYING COSMETIC PRODUCT RHEOLOGY | 2009 |
|
RU2503444C2 |
AMPHOLYTIC COPOLYMER BASED ON QUATERNISED NITROGEN-CONTAINING MONOMERS | 2007 |
|
RU2441029C2 |
AGENT FOR TREATMENT OF SENSITIVE SKIN, COMPOSITION BASED ON THEREOF AND METHOD OF SKIN TREATMENT | 1996 |
|
RU2180854C2 |
DONOR OF CHARGES FOR VESICULAR BEARING SYSTEM FOR UV PROTECTION FOR SKIN OR HAIR | 2012 |
|
RU2620337C2 |
PEPTIDES AND USE THEREOF IN SKIN CARE | 2015 |
|
RU2709778C2 |
USE OF CGRP-ANTAGONIST FOR TREATMENT OF SKIN REDDENING OF NEUROGENIC ORIGIN AND COMPOSITION BASED ON THEREOF | 1996 |
|
RU2152798C1 |
Authors
Dates
2011-02-10—Published
2005-05-24—Filed